ClinicalTrials.govpublic full text
Neo-adjuvant T-VEC + Nivolumab Combination Therapy for Resectable Early Metastatic (stage IIIB/C/D-IV M1a) Melanoma with Injectable Disease
melanoma stage iii, melanoma stage iv
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 172327
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.